Ionis Pharmaceuticals (IONS) Capital Expenditures (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Capital Expenditures of $16.1 million for Q2 2026, up 30.68% year-over-year from $12.3 million in Q2 2025, and down 26.11% quarter-over-quarter from $21.8 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Capital Expenditures (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Capital Expenditures history runs 18 years deep, the most recent figure standing at $16.1 million for Q2 2026.
- In Q2 2026, Capital Expenditures rose 30.68% year-over-year to $16.1 million; the TTM figure through Jun 2026 stood at $64.4 million (up 8.36% YoY), while the FY2025 annual figure was $51.4 million, up 13.61% from the prior year.
- Capital Expenditures for Q2 2026 stood at $16.1 million, down from $21.8 million in the prior quarter.
- The five-year high for Capital Expenditures was $25.5 million in Q4 2024, with the low at -$819000.0 in Q4 2023.
- The 5-year median for Capital Expenditures is $7.6 million (2024), against an average of $9.7 million.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures sank 119.79% in 2023, then surged 3213.19% in 2024.
- Ionis Pharmaceuticals' Capital Expenditures stood at $4.1 million in 2022, then tumbled by 119.79% to -$819000.0 in 2023, then soared by 3213.19% to $25.5 million in 2024, then retreated by 16.49% to $21.3 million in 2025, then decreased by 24.48% to $16.1 million in 2026.
- Business Quant data shows IONS's Capital Expenditures at $16.1 million in Q2 2026, $21.8 million in Q1 2026, and $21.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.08 Mn |
| Jun 30, 2026 | 16.08 Mn |
| Mar 31, 2026 | 21.76 Mn |
| Mar 31, 2026 | 21.76 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Sep 30, 2025 | 5.27 Mn |
| Sep 30, 2025 | 5.27 Mn |
| Jun 30, 2025 | 12.31 Mn |
| Jun 30, 2025 | 12.31 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Dec 31, 2024 | 25.50 Mn |
| Dec 31, 2024 | 25.50 Mn |
| Sep 30, 2024 | 9.06 Mn |
| Sep 30, 2024 | 9.06 Mn |
| Jun 30, 2024 | 6.23 Mn |
| Jun 30, 2024 | 6.23 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Mar 31, 2024 | 4.49 Mn |